Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Chemistry & Biodiversity|December 29, 2006
Comparative metabolism of alpha- and beta-peptides in the insect Heliothis virescens and in plant cells of black Mexican sweet maizeRob Lind, Daren Greenhow, Simon Perry, et al.RSC Medicinal Chemistry|June 24, 2024
Identification of SARS-CoV-2 Mpro inhibitors through deep reinforcement learning for <i>de novo</i> drug design and computational chemistry approachesJulien Hazemann, Thierry Kimmerlin, Roland Lange, et al.Chimia|October 27, 2017
The Screening Compound Collection: A Key Asset for Drug DiscoveryChristoph Boss, Julien Hazemann, Thierry Kimmerlin, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|February 22, 2003
Beta(2)/beta(3)-di- and alpha/beta(3)-tetrapeptide derivatives as potent agonists at somatostatin sst(4) receptorsCaroline Nunn, Magnus Rueping, Daniel Langenegger, et al.Chembiochem : a European Journal of Chemical Biology|March 10, 2009
A highly potent and cellularly active beta-peptidic inhibitor of the p53/hDM2 interactionMartin Hintersteiner, Thierry Kimmerlin, Geraldine Garavel, et al.Chemistry & Biodiversity|December 29, 2006
Pharmacokinetic investigation of a 14C-labelled beta 3/alpha tetrapeptide in ratsHansjörg Wiegand, Bernard Wirz, Alain Schweitzer, et al.Journal of Medicinal Chemistry|April 5, 2025
Accelerating the Hit-To-Lead Optimization of a SARS-CoV-2 Mpro Inhibitor Series by Combining High-Throughput Medicinal Chemistry and Computational SimulationsJulien Hazemann, Thierry Kimmerlin, Aengus Mac Sweeney, et al.Chemistry & Biology|July 29, 2009
Single bead labeling method for combining confocal fluorescence on-bead screening and solution validation of tagged one-bead one-compound librariesMartin Hintersteiner, Thierry Kimmerlin, Frank Kalthoff, et al.Journal of Medicinal Chemistry|September 26, 2025
Cellular Potency Optimization of Novel Heme-Binding Imidazo[5,1-<i>b</i>]thiazoles, Imidazo[1,5-<i>a</i>]pyridines and Pyrazines as Potent IDO1 Inhibitors Devoid of Cytochrome P450 InhibitionSylvaine Cren, Carina Lotz-Jenne, Thierry Kimmerlin, et al.Scientific Reports|November 13, 2024
Discovery and binding mode of small molecule inhibitors of the apo form of human TDO2Carina Lotz-Jenne, Roland Lange, Sylvaine Cren, et al.Pageof 2